The Amazing Race: Next-Gen Immuno-Oncology Edition

Read more about the two front-runners in this niche category and insights behind their race to market.

After several false starts and recent missteps, two promising new immuno-oncology classes could soon complement the reigning champions. At ASCO 2020, Roche/Genentech created buzz for their anti-TIGIT candidate. More recently, BMS upped the ante by announcing positive results for its anti-LAG-3 asset.

In this paper, Eric Blouin, Ipsos Healthcare SVP Oncology Research, analyzes the strengths and weaknesses of each class, and anticipates how the race might play out and what its impact on the cancer landscape could be. Unlike most contests, this one could have more than one winner!

Eric started his pharmaceutical career at Sandoz (Novartis) in Clinical Research, where he also worked on Phase IV post-approval studies and New Product Planning role. He has broad global experience in oncology research across solid tumors and hematological malignancies. Eric has worked extensively with targeted therapies and immunotherapies, as well as the emerging cell therapy field.

Download his paper today!

Download

The author(s)

  • Eric Blouin
    Senior Vice President, Healthcare Custom

Related news

  • NASPL Possible NW
    Consumer Behavior Event

    NASPL Possible NW

    Join Ipsos as we unveil how lotteries are using mystery shopping to unlock revenue hiding in plain sight, with high-performing retailers generating significantly more revenue per square foot through specific, measurable behaviours that any retailer can replicate.
  • [WEBINAR] 2025 KEYS: The Year in Review
    Consumers Events replay

    [WEBINAR] 2025 KEYS: The Year in Review

    Join Ipsos for its complimentary KEYS webinar series dedicated to helping brands and organizations better understand the dynamics of today as they prepare for tomorrow.
  • Coffee Association of Canada Conference
    Consumers Event

    Coffee Association of Canada Conference

    We’re excited to announce that Ipsos will be speaking at the Coffee Association of Canada’s Annual Conference on November 5 at Angus Glen Golf Club!